Patients with type 2 diabetes who use GLP-1 receptor agonists have a significantly lower risk for lung cancer than those who ...

Lung cancer remains the leading cause of cancer death, but advances in screening, surgery and personalized treatment are ...

Near-term applications include combinations with kinase inhibitors (KIs)that achieve enhanced concentration at target sites ...

Pharma companies are spending billions on a treatment based off old drugs, with little evidence it will extend lives.

Lung cancer remains the leading cause of cancer death in the U.S., responsible for about 1 in 4, but major advances in ...

One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, ...

It’s Lung Cancer Awareness Month, and we’re learning more about ground-breaking research and innovative treatments. They’re ...

According to the NCCN Guidelines for metastatic lung cancer, standard therapies remain valuable, but they are no longer sufficient on their own. This is why molecular profiling, targeted therapy, and ...

One person’s side effect could be another person’s treatment if we expand our perspective on small molecule drug targets, ...

This summer, 75-year-old Antioch Township Treasurer and Mesick resident Kathy Soerries was preparing for a family vacation to ...

New Zealanders living with multiple sclerosis, breast cancer, eye conditions, and lung cancer will benefit from five medicines that Pharmac will fund from 1 December 2025.

New Stanford research reveals older mice surprisingly developed fewer, smaller tumours, challenging the notion that cancer ...